TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇺🇸ACB

Aurora Cannabis Inc. - Common Shares

NASDAQ
$2.84
▼ $0.67 (-19.1%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 02 Jul 2026
H $5.04L $2.73-39.4%
$5.04$4.58$4.12$3.65$3.19$2.73$2.84
RSI (14)
Intraday · 15-minSell-20RSI 45SidewaysMACD Bearishfor day-trading context — not advice

Technical signal

Strong sell-60
RSI (14)36
oversold 30overbought 70
Trend
Downtrend
MACD
Bearish
Bollinger
Within bands
vs 20-day
below
vs 50-day
below
vs 200-day
below
Support
$2.73
Resistance
$3.63
  • Price is below its 50-day average (medium-term weakness).

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

Signal backtest · 2025-09-29 → 2026-07-02

Strategy return
-39.5%
Buy & hold
-54.4%
Trades
5
Win rate
0%

$100,000.00 invested would be worth $60,509.78 (-39.5%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Aurora Cannabis Inc.· Drug Manufacturers - Specialty & Generic

source: yahoo

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,028
Headquarters
Edmonton, Canada
www.auroramj.com ↗

Fundamentals· Semiconductors

demo data

Live data was unavailable (the free feed can be rate-limited or blocked by region/host), so sample figures are shown. Set FINNHUB_API_KEY for a reliable fallback.

Market cap
$311.17B
P/E
29.7
P/B
4.3
EPS
$14.91
Div yield
0.3%
Profit margin
28.9%
ROE
14.3%
Debt / Equity
0.98
Beta
1.45
52-week range
$310.26 – $554.03
52-week low · $310.260% of rangehigh · $554.03

Recent news

News sentiment:▲ Positive4↑ · 0↓ · 4–
  • TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell?▲ Positive
    Zacks · 02 Jul 2026
  • CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?— Neutral
    Zacks · 24 Jun 2026
  • Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Quarterly Update Report▲ Positive
    Exec Edge · 15 Jun 2026
  • Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge – Downloadable Quarterly Update Report

Fundamental data is informational only — not investment advice.

▲ Positive
Exec Edge · 15 Jun 2026
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector— Neutral
    Market Exclusive · 15 Jun 2026
  • Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs— Neutral
    Zacks · 12 Jun 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.